stockrowiRadimed Corporation
IRMD Healthcare Medical Devices
iRadimed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $83.8 million, up 14.4% from fiscal 2024.
- Revenue
- +14.2%
- EPS
- +15.9%
- Free cash flow
- +18.6%
Quarter to September 2026, against a year earlier
Follow IRMD
Alert me
iRadimed Corporation (IRMD) EV/Sales
As of 5 November 2026, iRadimed Corporation (IRMD) trades at a EV/Sales of 11.4×. Over the past ten years it has ranged from 1.9× (March 2017) to 15.4× (February 2026); the current reading is higher than 87% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 14.2× | 60.84% |
| FY2024 | 8.8× | 5.64% |
| FY2023 | 8.3× | 48.12% |
| FY2022 | 5.6× | (53.70%) |
| FY2021 | 12.1× | 71.68% |
| FY2020 | 7.1× | 25.31% |
| FY2019 | 5.6× | (24.86%) |
| FY2018 | 7.5× | 27.16% |
| FY2017 | 5.9× | 101.17% |
| FY2016 | 2.9× | (67.02%) |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Sep 2026 | 11.6× | (13.61%) |
| Jun 2026 | 13.5× | (1.05%) |
| Mar 2026 | 13.6× | (3.87%) |
| Dec 2025 | 14.2× | 34.29% |
| 43 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| AHCO AdaptHealth Corp. compare | 0.8× |
| LMRI Lumexa Imaging Holdings, Inc. compare | 1.2× |
| IART Integra LifeSciences Holdings Corporation compare | 1.6× |
| ATEC Alphatec Holdings, Inc. compare | 2.0× |
| PRCT PROCEPT BioRobotics Corporation compare | 2.8× |
| AORT Artivion, Inc. compare | 3.2× |
| SIBN SiBone compare | 4.4× |
| CBLL CeriBell, Inc. compare | 8.3× |
| IRMD iRadimed Corporation | 11.4× |
| Medical Devices industry median | 2.7× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)